Litigation Details for AbbVie Inc. v. Dr. Reddys Laboratories, Ltd. (D. Del. 2020)
✉ Email this page to a colleague
AbbVie Inc. v. Dr. Reddys Laboratories, Ltd. (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-07-21 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Mitchell S. Goldberg |
Jury Demand | None | Referred To | |
Parties | ABBVIE INC. | ||
Patents | 8,546,399; 8,722,657; 9,174,982 | ||
Attorneys | Samantha G. Wilson | ||
Firms | Saul Ewing Arnstein & Lehr LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AbbVie Inc. v. Dr. Reddys Laboratories, Ltd.
Details for AbbVie Inc. v. Dr. Reddys Laboratories, Ltd. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-07-21 | 3 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,546,399 ;9,174,982 ;8,722,657… 21 July 2020 1:20-cv-00968 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2021-07-21 | 53 | Notice of Service | Invalidity Contentions Relating to U.S. Patent Nos. 8,546,399 and 9,174,982 filed by Dr. Reddys Laboratories… 21 July 2020 1:20-cv-00968 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |